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A mouse monoclonal antibody (mAB 22-II-DSB) raised against lysed transformed human amnion cells (AMA) has been 
characterized. The mAB decorated the Golgi apparatus in growing and quiescent cultured monolayer cells (fibroblasts 
and epithelial cells) of various species as determined by double immunofluorescence labeling and colocalization with ga- 
lactosyltransferase antibodies. It reacted with the acidic human proteins IEF 58 (MT=29 000) and 57a, respectively 
(M, = 30 000) (HeLa protein catalogue number; [( 1982) Clin. Chem. 28, 7661). Golgi staining was also observed in BS-C- I 
cells microinjected with mAB 22-II-DSB suggesting that the epitopes recognized by the antibody are most likely located 
on the cytoplasmic face of the membranes. The precise localization of the antigens to the various cisternae of the Golgi 
apparatus could not be demonstrated by immunogold cytochemistry on ultrathin cryosections due to either weak reactiv- 
ity of the antibody or low concentration of the antigens. Immunofluorescence staining with mAB 22-II-D8B of lymphoid 
human Molt-4 cells and some human tissues failed to reveal any significant staining even though these expressed high 
levels of both IEF 58 and 57a. These results are taken to imply that the epitopes recognized by mAB 22-II-D8B may 
be masked in some cell types. 
Golgi associated protein; Monoclonal antibody; Cultured cell; Normal tissue: Tumor 
1. INTRODUCTION 
The Golgi apparatus is the organelle in which 
proteins destined to the plasma membrane, 
lysosomes and secretory vesicles are sorted ([l-6] 
and references therein). The Golgi apparatus is 
composed of well ordered stacks of membranes in 
which at least three compartments can be dis- 
tinguished cytochemically [l-6]. Proteins are 
believed to move from one compartment o the 
next by vesicular transport ([3-51 and references 
therein). Recently, Griffiths and Simons [5] have 
proposed a model for the Golgi complex in which 
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the last Golgi compartment, termed the tram 
-Golgi network (TGN) is responsible for routing 
proteins to their final destination. 
In this communication we report the 
characterization of a mouse monoclonal antibody 
(mAB 22-II-D8B) that stains the Golgi apparatus 
and reacts with human proteins IEF 58 and 57a 
(HeLa protein catalogue number; [7,8]). Further- 
more, we present evidence suggesting that the 
epitopes recognized by mAB 22-II-D8B are most 
likely located on the cytoplasmic face of the mem- 
branes. 
2. MATERIALS AND METHODS 
2.1. Cells 
All cultured cells used in this study were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10% fetal calf 
serum and antibiotics (100 units/ml penicillin, 50 pg/ml strep- 
tomycin). 
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2.2. Normal human tissues and tumours 
Fresh turnouts as well as surrounding normal tissues were ob- 
tained from the Pathology Department, Aarhus University. 
2.3. Immunization and monoclonal antibody production 
Human AMA cells lysed in hypotonic saline were used for 
immunization. Two-month-old BALB/c mice were injected in- 
traperitoneally with the equivalent of about lo6 cells and the 
procedure repeated twice at 2-week intervals. After a rest period 
of 1 week, spleen cells from immunized mice were fused with 
X63 myeloma cells according to standard procedures [9]. 
Hybridomas were screened by indirect immunofluorescence 
microscopy using methanol fixed AMA cells. A hybridoma 
(mAB 22-II-D8B) that reacted specifically with the Golgi ap- 
paratus of AMA cells was cloned twice by limited dilution using 
feeder cells (macrophages) to stimulate growth. 
The procedures for indirect immunofluorescence [lo], 
[35S]methionine-labeling [11,12], two-dimensional gel elec- 
trophoresis [13,14], immunoblotting [15,16], microinjection 
[ 17,181 and immunogold cytochemistry on ultrathin cryosec- 
tions [19] have been previously described. 
3. RESULTS 
3.1. mAB 22-II-D8B reacts with the Golgi 
apparatus in cultured cells 
Indirect immunofluorescence staining of AMA 
cells permeabilized and fixed in methanol (- 2O”C, 
5 min) showed that mAB 22-II-D8B stained the 
Golgi apparatus (fig. 1). Double immuno- 
fluorescence staining of AMA cells reacted with 
mAB 22-II-D8B (fig.lB) and a rabbit polyclonal 
antibody against human milk galactosyltransferase 
(found in the lumen of the trans Golgi cisternae, 
fig. 1C) [20] showed complete colocalization of the 
staining. The perinuclear staining was reticular in 
interphase cells, but looked scattered and frag- 
mented in mitotic cells. The precise localization of 
the antigens to the various cisternae could not be 
demonstrated by immunogold cytochemistry on 
ultrathin cryosections. Thus, specific labeling 
above the background level was not obtained. 
So far, Golgi staining with mAB 22-II-D8B has 
been observed in cultured monolayer cells (quies- 
cent as well as growing fibroblasts or epithelial 
cells) of all species analyzed. These include: bat 
(bat, CCL 88), dog (dog thymus), goat (goat 
synovial), hamster (CHO), mink (lung, CCL64), 
monkey (BS-C-l), mouse (3T3), potoroo (PTKl), 
rabbit (cornea, CCL 60) and rat (SV40 REF 52) 
(results not shown). 
Fig.1. Indirect immunofluorescence of methanol fixed AMA cells reacted with mAB 22-II-D8B. (A) Cells reacted with mAB 22-ll-D8B. 
(B,C) Double immunofluorescence of cells reacted with mAB 22-II-D8B (FITC) (B) and galactosyltransferase antibodies (rhodamine) 
(C). The arrows in B and C indicate identical cells. M = mitotic cell. 
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Fig.2. Identification of the antigens reacting with mAB 22-II-D8B by two-dimensional gel electrophoresis and immunoblotting. 
[?S]Methionine-labeled HeLa cell proteins were separated by two-dimensional gel electrophoresis (NEPHGE, IEF) and transferred 
to nitrocellulose sheets as described [15]. Antigens were identified by superposition of immunoblots with their corresponding (identical) 
autoradiograms. 
3.2. mAB 22-II-D8B reacts with the acidic human 
proteins IEF 58 and 57a (HeLa protein 
catalogue number) 
The specificity of mAB 22-II-D8B was deter- 
mined by two-dimensional gel immunoblotting 
(NEPHGE, IEF) of human AMA cell proteins. As 
shown in fig.2, the antibody reacts mainly with the 
acidic proteins IEF 58 (Mr = 29 000, HeLa protein 
catalogue number; [7,8]) and 57a (Mr = 30 000, 
HeLa protein catalogue number; [7,8]). For 
reference, the positions of IEF 58 and 57a re in- 
dicated in an IEF gel of [35S]methionine-labeled 
AMA cell proteins (fig.3). Proteins of similar 
molecular masses and pl have been observed in bat 
(bat CCL 88), goat (goat synovial), hamster 
(CHO), mouse (3T3), monkey (BS-C-1) and rat 
(SV40 REF 52) (results not shown) cultured 
monolayered cells, although the ratio between 
these proteins seems to be different. 
At present it is not known whether IEF 58 and 
16 
57a are related by modification, belong to a family 
of related proteins, or whether they are unrelated 
polypeptides sharing common antigenic deter- 
minants. Both proteins are synthesized in vitro in 
a reticulocyte cell free system incubated with 
polyA+ mRNA obtained from human MRC-5 
fibroblasts and their ratio is similar to that ob- 
served in vivo (results not shown). 
3.3. IEF 58 and 57a epitopes are most likely 
located on the cytoplasmic face of the Golgi 
membranes 
Evidence suggesting that either IEF 58, 57a or 
both epitopes are localized on the cytoplasmic face 
of the Golgi membranes was obtained by microin- 
jetting mAB 22-II-D8B into the cytoplasm of BS- 
C-l cells. Microinjected cells were fixed in 
methanol at various times after injection and were 
reacted with rhodamine-conjugated rabbit an- 
timouse immunoglobulins. Golgi staining was 
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Fig.3. Position of IEF 58 and 57a in a two-dimensional gel map (IEF) of [“Slmethionine-labeled proteins from HeLa cells. The 
position of actin, alpha tubulin (at), beta tubulin @t) and vimentin (v) are indicated for reference. 
observed early after injection (fig.4A; 20 min after 
injection) and remained unchanged even after pro- 
longed periods (up to 24 h). No Golgi staining was 
observed when BS-C-1 cells were injected with an- 
tibodies against galactosyltransferase, an enzyme 
found in the lumen of the Pans Golgi cisternae 
(fig.4B) [20]. Taken together these results sug- 
gested that mAB 22-II-D8B antigen is accessible to 
the antibody in intact cells and may be associated 
with the cytoplasmic face of the Golgi membranes. 
3.4. Epitopes recognized by mAB 22-II-D8B may 
be masked in some cultured cells and tissues 
Indirect immunofluorescence staining of 
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Fig.4. Cytoplasmic microinjection of BS-C-l cells with (A) mAB 22-II-D8B and (B) galactosyltransferase antibodies. Injected B-SC-1 
cells were fixed with methanol 20 min after injection. To visualize the first antibody the fixed cells were reacted with rhodamine 
conjugated second antibodies. The cytoplasmic staining observed in (B) is usually observed in cells injected with non-immune 
antibodies. 
Fig.5. Indirect immunofluorescence of cultured cells and human tissues. (A) Methanol fixed Molt-4 cells reacted with mAB 22.II-D8B. 
(B) As (A) but reacted with galactosyltransferase antibodies. (C) Methanol-fixed human epidermis reacted with mAB 22-II-D8B and 
(D) methanol-fixed human basal cell carcinoma reacted with mAB 22-II-DEB. 
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Fig.6. Presence of IEF 58 and 57a in Molt-4 cells. (A) IEF gel of [‘5S]methionine-labeled proteins. (B) Two-dimensional gel blot of 
Molt-4 proteins reacted with mAB 22-II-D8B. 
methanol fixed human lymphoid Molt-4 cells with 
mAB 22-II-DSB first suggested that the epitopes 
recognized by the antibody may be masked in some 
cell types. These cells do not stain with the an- 
tibody (fig.SA) in spite of the fact that they syn- 
thesize sizeable amounts of IEF 58 and 57a 
(fig.6A). Moreover, these proteins react with the 
antibody in two-dimensional gel immunoblots 
(fig.6B). Lack of staining with mAB 22-II-D8B is 
not due to a permeation artifact as these cells stain 
strongly with galactosyltransferase antibodies 
(fig.SB). Similar results to those described above 
have been observed with mouse myeloma cells 
(X63) and normal human epidermis (fig.SC; note 
that dermal fibroblasts stain brightly with the an- 
tibody). Interestingly, epidermal basal cells in 
basal cell carcinomas gave a positive staining with 
the antibody (fig.SD). The latter cells exhibit 
similar levels of IEF 58 and 57a s total epidermis 
[21]. Lack of staining with the antibody has been 
observed in various normal human tissues (brain, 
heart muscle, lung, skeletal muscle and pancreas; 
not shown) suggesting that this may be a generaliz- 
ed phenomenon. Some tumours (melanoma, car- 
diac tumour, lung adenocarcinoma, rectum 
carcinoma) on the other hand show a bright stain- 
ing with the antibody similar to that observed in 
cultured monolayer cells (results not shown). 
4. DISCUSSION 
This article describes the characterization of a 
mouse mAB that stains the Golgi apparatus and 
reacts with human proteins IEF 58 and 57a (HeLa 
protein catalogue number; [7,8]). By im- 
munofluorescence labeling we found that the 
monoclonal antibody colocalized with the 
galactosyl-transferase antibodies [20]. However, 
we were unable to localize the epitopes to a given 
cisterna using immunogold cytochemistry on 
ultrathin cryosections. This may be due to weak 
reactivity of the antibody, to the effect of aldehyde 
fixation, and/or to a small amount of the antigens. 
In the latter case, it should be noted that the la- 
beling efficiency of the gold technique is low [19]. 
Our observations of a fragmented immuno- 
fluorescence labeling of mitotic cells with the 
monoclonal antibody is in agreement with the find- 
ing of Lucocq and Warren [22] of Golgi fragmen- 
tation during mitosis. 
Evidence based on microinjection of mAB 22-11- 
D8B, suggested that the epitopes recognized by the 
antibody may be located on the cytoplasmic face 
of the Golgi membranes. Whether these proteins 
are integral membrane proteins or they are just 
bound to the cytoplasmic domain of the Golgi ap- 
paratus is at present unknown. So far, only a few 
proteins have been localized at the cytoplasmic do- 
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main of the Golgi apparatus. These include two 
peripheral membrane proteins of 54 and 86 kDa, 
respectively [23], and a microtubule-binding pro- 
tein of 110 kDa [24]. The latter protein is believed 
to link the Golgi apparatus to the microtubule net- 
work [24]. 
As far as we can judge from molecular mass 
estimates proteins IEF 58 and 57a re different to 
nicotinamide adenine dinucleotide phosphatase 
(medial Golgi) [25,26], N-acetyl glucosamine [27], 
thiamine pyrophosphatase (trans Golgi, TGN) 
[28], sialyl-transferase (trans Golgi, TGN) [29], 
acid phosphatase (TGN) [30] and the mannose 
6-phosphate receptor (Golgi complex, small 
vesicles (clathrin-like coats) and larger vesicles) 
(for reviews see [31-331). Also, IEF 58 and 57a re 
different to other Goigi proteins of unknown func- 
tion [34,35]. 
At present, it is not known why the epitopes 
recognized by mAB 22-II-D8B are masked in some 
cultured cells and tissues. It is possible that this 
reflects dissimilarities in the orientation of the 
molecules in the membrane, resulting in a differen- 
tial availability of the epitopes. Further studies will 
be necessary to unravel the molecular mechanisms 
responsible for the differential reactivity of various 
cultured cell types and tissues with the antibody. 
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